Dr. Chetan Huded, MD
Claim this profileSaint Luke's Hospital of Kansas City
Studies Tricuspid Regurgitation
Studies Tricuspid Valve Disease
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Saint Luke's Hospital Of Kansas City
St. Luke's Hospital Of Kansas City
Clinical Trials Chetan Huded, MD is currently running
Edwards PASCAL System
for Tricuspid Regurgitation
This trial tests a new device that fixes a leaky heart valve without surgery in patients who are too risky for traditional surgery. The device helps the valve close properly to stop blood from leaking backward. The first device specifically designed for this purpose is the paravalvular leak device (PLD - Occlutech).
Recruiting1 award N/A6 criteria
Amplatzer Plug
for Aortic Regurgitation
The Paradigm study is a prospective, multicenter, single arm study to demonstrate the safety and effectiveness of the Amplatzer Valvular Plug III (AVP III) as a treatment for clinically significant PVLs following surgical implant of a mechanical or biological heart valve implanted in the aortic or mitral position.
Recruiting1 award N/A6 criteria
More about Chetan Huded, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Chetan Huded, MD has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- WATCHMAN FLX LAAC Device
- Non-Vitamin K Oral Anticoagulant
- Amplatzer Valvular Plug III
Breakdown of trials Chetan Huded, MD has run
Tricuspid Regurgitation
Tricuspid Valve Disease
Atrial Fibrillation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chetan Huded, MD specialize in?
Chetan Huded, MD focuses on Tricuspid Regurgitation and Tricuspid Valve Disease. In particular, much of their work with Tricuspid Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Chetan Huded, MD currently recruiting for clinical trials?
Yes, Chetan Huded, MD is currently recruiting for 2 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Chetan Huded, MD has studied deeply?
Yes, Chetan Huded, MD has studied treatments such as Edwards PASCAL System, Optimal Medical Therapy, WATCHMAN FLX LAAC Device.
What is the best way to schedule an appointment with Chetan Huded, MD?
Apply for one of the trials that Chetan Huded, MD is conducting.
What is the office address of Chetan Huded, MD?
The office of Chetan Huded, MD is located at: Saint Luke's Hospital of Kansas City, Kansas City, Missouri 64111 United States. This is the address for their practice at the Saint Luke's Hospital of Kansas City.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.